Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11680062
3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease
granted -
US 11679103
Multi-targeting agents for Alzheimer's disease therapy
granted -
US 11679112
Cancer treatments using combinations of CDK and ERK inhibitors
granted -
US 11679113
Anticancer treatment for uveal melanoma
granted -
US 11679143
FGF21 variant, fusion protein and application thereof
granted -
US 11679078
Ophthalmic formulations and related methods
granted -
US 11679109
SMARCA degraders and uses thereof
granted -
US 11679079
Ophthalmic formulations and related methods
granted -
US 11679101
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 11679100
Methods of enhancing immunity
granted -
US 11680036
Methods for making and using endoxifen
granted -
US 11679150
Mycoplasma bovis vaccine product
granted -
US 11679161
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
granted -
KR 20230088753
파킨슨병 치료를 위한 오피카폰 및 레보도파
granted -
US 11679075
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
granted -
US 11679119
Bortezomib compositions
granted -
US 11679158
Biodegradable lipids for the delivery of active agents
granted -
US 11679131
Genetically engineered T cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
granted -
US 11680034
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
granted -
US 11679159
Compositions for transfecting resistant cell types
granted -
US 11680254
Engineered meganucleases specific for recognition sequences in the PCSK9 gene
granted -
US 11679157
Controlled release mucoadhesive systems
granted -
US 11680249
Adeno-associated virus capsid variants and methods of use thereof
granted -
US 11680093
Monoclonal antibodies that specifically bind to matrilin 3 and their use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.